FOCALFLEX (CE Mark) Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT06271967
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT06271967
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Australia, Austria, Belgium, Czechia, Denmark, France, Germany, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT06271967. Allocation not applicable; no masking; primary purpose treatment. Start 2024-08-15 (actual); primary completion 2025-07-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FOCALFLEX (CE Mark) Study
- Condition
- Atrial Fibrillation Paroxysmal
- Intervention (Device)
- TactiFlex™ Ablation Catheter Sensor Enabled™
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct06271967- Content hash
215bcca6d9cee50af979a31bb6024fec43d5dfd5964e96fca3938a2c549cf475